CN1854294A - 分泌表达重组人表皮生长因子的大肠杆菌表达*** - Google Patents
分泌表达重组人表皮生长因子的大肠杆菌表达*** Download PDFInfo
- Publication number
- CN1854294A CN1854294A CNA2005100252893A CN200510025289A CN1854294A CN 1854294 A CN1854294 A CN 1854294A CN A2005100252893 A CNA2005100252893 A CN A2005100252893A CN 200510025289 A CN200510025289 A CN 200510025289A CN 1854294 A CN1854294 A CN 1854294A
- Authority
- CN
- China
- Prior art keywords
- rhegf
- pbl10egf
- gene
- phoaspl10
- expression plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003248 secreting effect Effects 0.000 title claims description 15
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 title description 27
- 229940116978 human epidermal growth factor Drugs 0.000 title description 24
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 title description 24
- 241000588722 Escherichia Species 0.000 title description 3
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 29
- 239000013613 expression plasmid Substances 0.000 claims abstract description 22
- 108010076504 Protein Sorting Signals Proteins 0.000 claims abstract description 13
- 238000002360 preparation method Methods 0.000 claims abstract description 10
- 238000000855 fermentation Methods 0.000 claims abstract description 8
- 230000004151 fermentation Effects 0.000 claims abstract description 8
- 241000588724 Escherichia coli Species 0.000 claims abstract description 7
- 241000894006 Bacteria Species 0.000 claims description 21
- 239000013612 plasmid Substances 0.000 claims description 9
- 238000012216 screening Methods 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 8
- 238000000926 separation method Methods 0.000 claims description 7
- 230000001939 inductive effect Effects 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 238000010353 genetic engineering Methods 0.000 claims description 5
- 230000028327 secretion Effects 0.000 claims description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 238000004587 chromatography analysis Methods 0.000 claims description 3
- 238000002523 gelfiltration Methods 0.000 claims description 3
- 230000002209 hydrophobic effect Effects 0.000 claims description 3
- 238000010792 warming Methods 0.000 claims description 3
- 238000010276 construction Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 6
- 230000004071 biological effect Effects 0.000 abstract description 4
- 102000004169 proteins and genes Human genes 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 description 19
- 239000000047 product Substances 0.000 description 15
- 108020004414 DNA Proteins 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- 238000013016 damping Methods 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 102000004190 Enzymes Human genes 0.000 description 9
- 108090000790 Enzymes Proteins 0.000 description 9
- 238000013461 design Methods 0.000 description 9
- 235000015097 nutrients Nutrition 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
- 239000012153 distilled water Substances 0.000 description 8
- 238000005516 engineering process Methods 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 8
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 238000012549 training Methods 0.000 description 7
- 238000011084 recovery Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 230000000968 intestinal effect Effects 0.000 description 5
- 108091008146 restriction endonucleases Proteins 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000012634 fragment Substances 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 239000012980 RPMI-1640 medium Substances 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000012010 growth Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 2
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 239000004160 Ammonium persulphate Substances 0.000 description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 2
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 2
- 108010026552 Proteome Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 235000019395 ammonium persulphate Nutrition 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000013401 experimental design Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical class [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000003277 amino acid sequence analysis Methods 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000003981 ectoderm Anatomy 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000012407 engineering method Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethyl mercaptane Natural products CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 125000003147 glycosyl group Chemical group 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000003000 inclusion body Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 201000008261 skin carcinoma Diseases 0.000 description 1
- 235000011091 sodium acetates Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 206010041823 squamous cell carcinoma Diseases 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical group C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
浓缩胶(5%) | 分离胶(15%) | ||
水 | 2ml | 水 | 2.7ml |
0.75M Tris·HCl(pH6.8) | 0.4ml | 1.5M Tris·HCl(pH8.8) | 2ml |
30%丙烯酰胺 | 0.5ml | 30%丙烯酰胺 | 5ml |
10%SDS | 30μl | 10%SDS | 100μl |
10%过硫酸铵 | 30μl | 10%过硫酸铵 | 100μl |
10%TEMED | 30μl | 10%TEMED | 100μl |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100252893A CN100489096C (zh) | 2005-04-21 | 2005-04-21 | 分泌表达重组人表皮生长因子的大肠杆菌表达*** |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100252893A CN100489096C (zh) | 2005-04-21 | 2005-04-21 | 分泌表达重组人表皮生长因子的大肠杆菌表达*** |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1854294A true CN1854294A (zh) | 2006-11-01 |
CN100489096C CN100489096C (zh) | 2009-05-20 |
Family
ID=37194745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100252893A Active CN100489096C (zh) | 2005-04-21 | 2005-04-21 | 分泌表达重组人表皮生长因子的大肠杆菌表达*** |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100489096C (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102212596A (zh) * | 2010-04-01 | 2011-10-12 | 孙民富 | 一种生产人表皮生长因子(egf)的制备方法 |
CN102952817A (zh) * | 2011-08-16 | 2013-03-06 | 上海昊海生物科技股份有限公司 | 一种采用温度诱导生产重组人表皮生长因子的方法 |
CN103060249A (zh) * | 2012-06-06 | 2013-04-24 | 浙江普洛康裕制药有限公司 | 大肠埃希氏菌及由其高效分泌表达人表皮生长因子的方法 |
CN103834676A (zh) * | 2014-02-28 | 2014-06-04 | 中国科学院福建物质结构研究所 | 一种大肠杆菌分泌表达外源蛋白的质粒载体及其构建方法 |
CN107987150A (zh) * | 2017-12-19 | 2018-05-04 | 江苏艾迪药业有限公司 | 一种可工业化生产的从尿液中制备人表皮生长因子的方法 |
CN110564661A (zh) * | 2019-09-23 | 2019-12-13 | 杭州纽龙生物科技有限公司 | 一种培养表达重组人表皮生长因子的工程菌的方法 |
CN112175063A (zh) * | 2020-10-28 | 2021-01-05 | 宁波博睿瀚达生物科技有限公司 | 一种高效液相色谱法制备高纯度重组表皮生长因子的工艺 |
CN112209999A (zh) * | 2020-10-28 | 2021-01-12 | 宁波博睿瀚达生物科技有限公司 | 一种快速分离重组表皮生长因子发酵液中色素的方法 |
CN116555310A (zh) * | 2023-03-28 | 2023-08-08 | 广州汉方合成生物研究中心(有限合伙) | 一种高通量筛选异源组成型启动子的方法及其应用 |
-
2005
- 2005-04-21 CN CNB2005100252893A patent/CN100489096C/zh active Active
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102212596A (zh) * | 2010-04-01 | 2011-10-12 | 孙民富 | 一种生产人表皮生长因子(egf)的制备方法 |
CN102952817A (zh) * | 2011-08-16 | 2013-03-06 | 上海昊海生物科技股份有限公司 | 一种采用温度诱导生产重组人表皮生长因子的方法 |
CN102952817B (zh) * | 2011-08-16 | 2014-07-09 | 上海昊海生物科技股份有限公司 | 一种采用温度诱导生产重组人表皮生长因子的方法 |
CN103060249A (zh) * | 2012-06-06 | 2013-04-24 | 浙江普洛康裕制药有限公司 | 大肠埃希氏菌及由其高效分泌表达人表皮生长因子的方法 |
CN103834676A (zh) * | 2014-02-28 | 2014-06-04 | 中国科学院福建物质结构研究所 | 一种大肠杆菌分泌表达外源蛋白的质粒载体及其构建方法 |
CN107987150A (zh) * | 2017-12-19 | 2018-05-04 | 江苏艾迪药业有限公司 | 一种可工业化生产的从尿液中制备人表皮生长因子的方法 |
CN110564661A (zh) * | 2019-09-23 | 2019-12-13 | 杭州纽龙生物科技有限公司 | 一种培养表达重组人表皮生长因子的工程菌的方法 |
CN112175063A (zh) * | 2020-10-28 | 2021-01-05 | 宁波博睿瀚达生物科技有限公司 | 一种高效液相色谱法制备高纯度重组表皮生长因子的工艺 |
CN112209999A (zh) * | 2020-10-28 | 2021-01-12 | 宁波博睿瀚达生物科技有限公司 | 一种快速分离重组表皮生长因子发酵液中色素的方法 |
CN116555310A (zh) * | 2023-03-28 | 2023-08-08 | 广州汉方合成生物研究中心(有限合伙) | 一种高通量筛选异源组成型启动子的方法及其应用 |
CN116555310B (zh) * | 2023-03-28 | 2024-03-29 | 广州市金因源生物技术有限公司 | 一种高通量筛选异源组成型启动子的方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN100489096C (zh) | 2009-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1854294A (zh) | 分泌表达重组人表皮生长因子的大肠杆菌表达*** | |
CN1023900C (zh) | 人初级成纤维细胞生长因子的制备方法 | |
CN1105777C (zh) | 由氧化葡糖杆菌t-100得到的l-山梨糖脱氢酶及其制备方法 | |
CN1311076C (zh) | 生产重组尿激酶的方法 | |
CN1807456A (zh) | 重组人甲状旁腺激素pth1-34的制备方法 | |
CN1887349A (zh) | 基于尿素酶b亚单位活性片段的幽门螺杆菌疫苗及其制备方法 | |
CN101063104A (zh) | 一种生产5-氨基乙酰丙酸的工程菌及其构建方法 | |
CN1551918A (zh) | 基因重组伊卡因及其制备方法 | |
CN1990871A (zh) | 重组人纤溶酶原Kringle 5(hk5)生产方法 | |
CN1374970A (zh) | 用于由大肠杆菌向培养基中分泌来制备Leu-水蛭素的信号序列 | |
CN1511849A (zh) | 新型α干扰素突变体及其制备方法 | |
CN1766107A (zh) | 一种重组人角质细胞生长因子的生产方法 | |
CN101045933A (zh) | 一种适冷蛋白酶的基因mcp01及其制备方法 | |
CN1699424A (zh) | 一种肝素酶i融合蛋白及其编码基因与表达方法 | |
CN1052509C (zh) | 生产腈水化酶的方法 | |
CN1177928A (zh) | 生产人胰岛素 | |
CN1194006A (zh) | 利用双加氧酶生物转化与化学步骤相结合的茚向无任何立体异构体的(is)-氨基-(2r)-茚满醇的转化 | |
CN1597697A (zh) | 一种人的甲状旁腺素1-34肽相关肽-Pro-Pro-[Arg11]]hPTH(1-34)-Pro-Pro | |
CN1181199C (zh) | 地衣形芽孢杆菌l-25角蛋白酶及编码该角蛋白酶的dna | |
CN101067138A (zh) | 基因工程制备人毛***细胞hspc016蛋白质的方法、表达载体和工程菌 | |
CN100347294C (zh) | 一种热稳定海藻糖合成酶及其编码基因与应用 | |
CN1065292A (zh) | 大量制备戊二酰酰基转移酶的方法 | |
CN1295332C (zh) | 一种重组人碱性成纤维细胞生长因子基因及其非融合表达产物、生产方法和应用 | |
CN1084565A (zh) | 具有腈水合酶活性的新型蛋白和编码该蛋白的基因 | |
CN100340656C (zh) | 人γ-干扰素在毕赤酵母菌中的高效表达、发酵和纯化 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Shanghai Haohai Biological Technology Co., Ltd. Assignor: Ye Qin|Feng Baoshan|Zhu Jun|Qian Yue|Ding Hongzhen|Gan Bao|Zhang Haiyi|Zhang Qian Contract record no.: 2011310000122 Denomination of invention: Escherichia expression system of secretory expression recombinant human epidermal growth factor Granted publication date: 20090520 License type: Exclusive License Open date: 20061101 Record date: 20110729 |
|
ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: QIAN YUE ZHU JUN FENG BAOSHAN DING HONGZHEN ZHANG QIAN YE QIN ZHANG HAIYI Owner name: SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: GAN RENBAO Effective date: 20110822 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 200032 XUHUI, SHANGHAI TO: 200052 CHANGNING, SHANGHAI |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110822 Address after: 200052 Building 2, building 139, Lane 5, Anshun Road, Shanghai, China Patentee after: Shanghai Haohai Biological Technology Co., Ltd. Address before: 200032 Shanghai City Wanping Road No. 34 Lane 255, room 2801 Co-patentee before: Qian Yue Patentee before: Gan Renbao Co-patentee before: Zhu Jun Co-patentee before: Feng Baoshan Co-patentee before: Ding Hongzhen Co-patentee before: Zhang Qian Co-patentee before: Ye Qin Co-patentee before: Zhang Haiyi |